Resveratrol, a natural compound, has been suggested for consideration in combination therapy as it can enhance the response of cancer cells to PARP inhibitors and reduce inflammation in the heart mediated by NLRP3 [28,29]. This evidence concerns the gene NLRP3 and cancer.